📰 Affinity Technologies Inc News
Page 4 - Affinity Technologies Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Affinity Technologies Inc. Real-time updates on events, politics, business and more.
January 8, 2024
SAN ANTONIO--(BUSINESS WIRE)--Jan 8, 2024--
January 8, 2024
Here is a summary of the latest news about bioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung...
December 19, 2023
Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy program. Compugen shares jumped 204.1% to $2.22 on Tuesday.
December 5, 2023
BioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung disease, today announced the appointment of Jamie...
December 1, 2023
SAN ANTONIO - bioAffinity Technologies, Inc. , a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other lung diseases, today announced that the...
November 30, 2023
BIAF | Complete bioAffinity Technologies Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
November 28, 2023
BioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer and lung disease, today announced that David Elzi,...
November 21, 2023
BioAffinity Technologies (NASDAQ:BIAF – Get Free Report) and Guardant Health (NASDAQ:GH – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership and risk. Institutional & Insider Ownership 1.1% of bioAffinity Technologies […]
November 14, 2023
14.11.2023 - bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three and nine months ...
November 6, 2023
BioAffinity Technologies, Inc. announced the appointment of Dallas J. Coleman as National Director of Sales. Mr. Coleman has more than 15 years of experience in medical sales and marketing, most...